Literature DB >> 11891319

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.

Luca Roz1, Marcella Gramegna, Hideshi Ishii, Carlo M Croce, Gabriella Sozzi.   

Abstract

Loss of expression of the Fhit protein is often associated with the development of many human epithelial cancers, including lung and cervical carcinomas. Restoration of Fhit expression in cell lines derived from these tumors has however yielded conflicting results, prompting the need for careful evaluation of the oncosuppressive potential of FHIT. In the present study, we have investigated the effect of Fhit reintroduction in seven lung cancer and three cervical cancer cell lines. To achieve efficient gene transfer and high levels of transgene expression, we have used an adenoviral vector to transduce the FHIT gene. The induction of apoptosis was evaluated by using the terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assay and propidium iodide staining. Activation of caspases was detected by using Western blot analysis, and tumorigenic potential of transduced cells in the nude mouse was also assessed. Restoration of Fhit expression induced apoptosis in all Fhit-negative cell lines, with Calu-1, H460, and A549 being the most susceptible among the lung cancer cell lines and SiHa cells among cervical carcinomas. Activation of caspase-8 was always associated with Fhit-mediated apoptosis, and in vivo tumorigenicity was either abolished by FHIT gene transfer (in H460 and SK-Mes cells) or strongly suppressed (in A549 and SiHa cells). Our data demonstrate oncosuppressive properties and strong proapoptotic activity of the Fhit protein in lung and cervical cancer cell lines and strengthens the hypothesis of its possible use as a therapeutic tool.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891319      PMCID: PMC122572          DOI: 10.1073/pnas.062030799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.

Authors:  D C Connolly; D L Greenspan; R Wu; X Ren; R L Dunn; K V Shah; R W Jones; F X Bosch; N Muñoz; K R Cho
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

2.  FHIT gene therapy prevents tumor development in Fhit-deficient mice.

Authors:  K R Dumon; H Ishii; L Y Fong; N Zanesi; V Fidanza; R Mancini; A Vecchione; R Baffa; F Trapasso; M J During; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

Authors:  H Ishii; K R Dumon; A Vecchione; F Trapasso; K Mimori; H Alder; M Mori; G Sozzi; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

4.  Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.

Authors:  K R Dumon; H Ishii; A Vecchione; F Trapasso; G Baldassarre; F Chakrani; T Druck; E F Rosato; N N Williams; R Baffa; M J During; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

5.  Expression of truncated FHIT transcripts in cervical cancers and in normal human cells.

Authors:  C P Matthews; K Shera; N Kiviat; J K McDougall
Journal:  Oncogene       Date:  2001-08-02       Impact factor: 9.867

6.  Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.

Authors:  R Baffa; L G Gomella; A Vecchione; P Bassi; K Mimori; J Sedor; C M Calviello; M Gardiman; C Minimo; S E Strup; P A McCue; A J Kovatich; F Pagano; K Huebner; C M Croce
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.

Authors:  R Wu; D C Connolly; R L Dunn; K R Cho
Journal:  J Natl Cancer Inst       Date:  2000-02-16       Impact factor: 13.506

8.  Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

Authors:  N S Werner; Z Siprashvili; L Y Fong; G Marquitan; J K Schröder; W Bardenheuer; S Seeber; K Huebner; J Schütte; B Opalka
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

9.  Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.

Authors:  M Mori; K Mimori; T Shiraishi; H Alder; H Inoue; Y Tanaka; K Sugimachi; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

10.  FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.

Authors:  M Campiglio; Y Pekarsky; S Menard; E Tagliabue; S Pilotti; C M Croce
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

View more
  33 in total

1.  Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases.

Authors:  Charles Brenner
Journal:  Biochemistry       Date:  2002-07-23       Impact factor: 3.162

2.  Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway.

Authors:  Yan Li; Wei Yin; Xia Wang; Wenbo Zhu; Yijun Huang; Guangmei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

Review 3.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

4.  Crystallization and preliminary X-ray crystallographic analysis of SMU.412c protein from the caries pathogen Streptococcus mutans.

Authors:  Zhao Yang Ye; Qiao Ming Hou; Lan Fen Li; Xiao Dong Su
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-03-25

5.  FHIT promoter DNA methylation and expression analysis in childhood acute lymphoblastic leukemia.

Authors:  Gholamreza Bahari; Mohammad Hashemi; Majid Naderi; Simin Sadeghi-Bojd; Mohsen Taheri
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

6.  Recent findings on epigenetic gene abnormalities involved in uterine cancer.

Authors:  Megumi Yanokura; Kouji Banno; Yusuke Kobayashi; Hiroyuki Nomura; Shigenori Hayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2017-09-20

7.  Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.

Authors:  Francesco Trapasso; Agnieszka Krakowiak; Rossano Cesari; Jeffrey Arkles; Sai Yendamuri; Hideshi Ishii; Andrea Vecchione; Tamotsu Kuroki; Pawel Bieganowski; Helen C Pace; Kay Huebner; Carlo M Croce; Charles Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

8.  Genome wide DNA-profiling of HIV-related B-cell lymphomas.

Authors:  Daniela Capello; Marta Scandurra; Giulia Poretti; Paola M V Rancoita; Michael Mian; Annunziata Gloghini; Clara Deambrogi; Maurizio Martini; Davide Rossi; Timothy C Greiner; Wing C Chan; Maurilio Ponzoni; Santiago M Moreno; Miguel A Piris; Vincenzo Canzonieri; Michele Spina; Umberto Tirelli; Giorgio Inghirami; Andrea Rinaldi; Emanuele Zucca; Riccardo D Favera; Franco Cavalli; Luigi Maria Larocca; Ivo Kwee; Antonino Carbone; Gianluca Gaidano; Francesco Bertoni
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

9.  Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.

Authors:  F Andriani; P Perego; N Carenini; G Sozzi; L Roz
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

10.  Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas.

Authors:  Naoki Yanagawa; Mitsumasa Osakabe; Masahiro Hayashi; Gen Tamura; Teiichi Motoyama
Journal:  Virchows Arch       Date:  2008-02-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.